Xing Wang

USPTO Granted Patents = 25 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 7.6

ph-index = 7

Forward Citations = 155(Granted Patents)

Location History:

Emeryville, CA (US) (2011)
San Diego, CA (US) (2008 - 2023)

Company Filing History:

The Scripps Research Institute

patents

5. 1 out of 1

Irm Llc, a Delaware Limited Liability Company

patent

where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49556 - Compounds and compositions as protein kinase inhibitors (2023-06-19),

2. 10973826 - Antibody conjugates comprising toll-like receptor agonist (2021-04-13),

3. 10787480 - Cytotoxic peptides and conjugates thereof (2020-09-29),

4. 10576080 - Compounds and compositions as protein kinase inhibitors (2020-03-03),

5. 10568884 - Compounds and compositions as protein kinase inhibitors (2020-02-25),

6. 10392421 - Cytotoxic peptides and conjugates thereof (2019-08-27),

7. 10280139 - Cytotoxic peptides and conjugates thereof (2019-05-07),

8. 10005761 - Compounds and compositions as protein kinase inhibitors (2018-06-26),

9. 9988420 - Cytotoxic peptides and conjugates thereof (2018-06-05),

10. 9884817 - Auristatin derivatives and conjugates thereof (2018-02-06),

11. 9850230 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

12. 9850229 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

13. 9593100 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

14. 9593099 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

15. 9580426 - Compounds that expand hematopoietic stem cells (2017-02-28),

Title: Pioneer in Pharmaceutical Innovations: The Inventor Xing Wang

Introduction: Xing Wang, a brilliant inventor based in San Diego, CA (US), has made significant contributions to the field of pharmaceuticals with a total of 25 patents under his belt.

Latest Patents: Wang's latest patents showcase his ingenuity in the pharmaceutical realm. One patent involves compounds and compositions as protein kinase inhibitors, offering a new class of compounds to treat diseases with abnormal kinase activity. Another patent focuses on antibody conjugates containing toll-like receptor agonists for cancer treatment, with specific emphasis on anti-HER2 antibodies.

Career Highlights: Throughout his career, Wang has collaborated with renowned companies such as Novartis and Array Biopharma Inc. His work in these organizations has propelled the development of innovative pharmaceutical solutions, solidifying his reputation as a pioneer in the industry.

Collaborations: Wang's collaborations with esteemed coworkers Yongqin Wan and Yongping Xie have been instrumental in pushing the boundaries of pharmaceutical research. Together, they have worked on cutting-edge projects that have the potential to revolutionize the treatment of various diseases.

Conclusion: Xing Wang's remarkable inventiveness and dedication to advancing pharmaceutical innovations have not only earned him numerous patents but also positioned him as a key figure in the industry. His groundbreaking work continues to inspire future generations of inventors in the quest for groundbreaking medical solutions.

This text is generated by artificial intelligence and may not be accurate.